Literature DB >> 28811689

Expression of Telomere Binding Proteins (RAP1 and POT1) in Renal Cell Carcinoma and Their Correlation with Clinicopathological Parameters.

Deeksha Pal1,2, Shrawan Kumar Singh3, Nandita Kakkar4, Rajendra Prasad1.   

Abstract

Telomere stability is indispensable for continuous proliferation of cells. Telomere structure is maintained by group of six proteins termed as shelterin. RAP1 and POT1 proteins are significant members of shelterin complex. Expression of RAP1 and POT1 are crucial for telomere maintenance and hence uncontrolled division of cells. Notably, expression of RAP1 and POT1 is unknown in renal cell carcinoma (RCC). In view of these facts, the present study was initiated to investigate the expression of RAP1 and POT1 in RCC and their relationships with clinicopathological features. In total 65 histopathologically confirmed RCC cases and their adjacent normal renal parenchyma were analyzed for gene expression. The mRNA expression of telomere binding proteins RAP1 and POT1 were measured using RT-PCR. Expression of RAP1 was observed to be significantly increased in tumour tissues as compared to corresponding normal renal tissues (P = 0.004). The gene expression of RAP1 was documented to be related to grades of RCC (P = 0.002) and subtypes of RCC (P = 0.01). Although, POT1 expression was up-regulated in RCC tissue, however it was not statistically significant. Also, POT1 expression was not related to grades, stages and subtypes of RCC. This is the first study which shows correlation RAP1 with grades and subtypes of RCC.

Entities:  

Keywords:  Cancer; Correlation; Genomics; Kidney; POT 1; RAP1

Year:  2016        PMID: 28811689      PMCID: PMC5539006          DOI: 10.1007/s12291-016-0611-8

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  25 in total

Review 1.  Structure and function of telomeres.

Authors:  E H Blackburn
Journal:  Nature       Date:  1991-04-18       Impact factor: 49.962

2.  Clinical significance of telomerase and its associate genes expression in the maintenance of telomere length in squamous cell carcinoma of the esophagus.

Authors:  Chung-Ping Hsu; Li-Wen Lee; Sen-Ei Shai; Chih-Yi Chen
Journal:  World J Gastroenterol       Date:  2005-11-28       Impact factor: 5.742

3.  Analyzing real-time PCR data by the comparative C(T) method.

Authors:  Thomas D Schmittgen; Kenneth J Livak
Journal:  Nat Protoc       Date:  2008       Impact factor: 13.491

4.  Expression of telomere-associated genes as prognostic markers for overall survival in patients with non-small cell lung cancer.

Authors:  Xin Lin; Jian Gu; Charles Lu; Margaret R Spitz; Xifeng Wu
Journal:  Clin Cancer Res       Date:  2006-10-01       Impact factor: 12.531

Review 5.  Telomeres: protecting chromosomes against genome instability.

Authors:  Roderick J O'Sullivan; Jan Karlseder
Journal:  Nat Rev Mol Cell Biol       Date:  2010-02-03       Impact factor: 94.444

6.  Human POT1 facilitates telomere elongation by telomerase.

Authors:  Lorel M Colgin; Katherine Baran; Peter Baumann; Thomas R Cech; Roger R Reddel
Journal:  Curr Biol       Date:  2003-05-27       Impact factor: 10.834

7.  Expression of POT1 is associated with tumor stage and telomere length in gastric carcinoma.

Authors:  Tomohiro Kondo; Naohide Oue; Kazuhiro Yoshida; Yoshitsugu Mitani; Kazuhito Naka; Hirofumi Nakayama; Wataru Yasui
Journal:  Cancer Res       Date:  2004-01-15       Impact factor: 12.701

8.  Prognostic significance of morphologic parameters in renal cell carcinoma.

Authors:  S A Fuhrman; L C Lasky; C Limas
Journal:  Am J Surg Pathol       Date:  1982-10       Impact factor: 6.394

Review 9.  Shelterin: the protein complex that shapes and safeguards human telomeres.

Authors:  Titia de Lange
Journal:  Genes Dev       Date:  2005-09-15       Impact factor: 12.890

10.  DNA-PKcs phosphorylates hnRNP-A1 to facilitate the RPA-to-POT1 switch and telomere capping after replication.

Authors:  Jiangdong Sui; Yu-Fen Lin; Kangling Xu; Kyung-Jong Lee; Dong Wang; Benjamin P C Chen
Journal:  Nucleic Acids Res       Date:  2015-05-20       Impact factor: 16.971

View more
  4 in total

1.  Roles of telomeres and telomerase in age‑related renal diseases (Review).

Authors:  Haili Li; Boyuan Wang; Daoqun Li; Jinyuan Li; Ying Luo; Juhua Dan
Journal:  Mol Med Rep       Date:  2020-12-10       Impact factor: 2.952

2.  Identification of C3 and FN1 as potential biomarkers associated with progression and prognosis for clear cell renal cell carcinoma.

Authors:  Yang Dong; Wei-Ming Ma; Wen Yang; Lin Hao; Shao-Qi Zhang; Kun Fang; Chun-Hui Hu; Qian-Jin Zhang; Zhen-Duo Shi; Wen-da Zhang; Tao Fan; Tian Xia; Cong-Hui Han
Journal:  BMC Cancer       Date:  2021-10-23       Impact factor: 4.430

Review 3.  RAP1/TERF2IP-A Multifunctional Player in Cancer Development.

Authors:  Anna Deregowska; Maciej Wnuk
Journal:  Cancers (Basel)       Date:  2021-11-27       Impact factor: 6.639

4.  Telomere-related Markers for Cancer.

Authors:  Xiaotian Yuan; Mingkai Dai; Dawei Xu
Journal:  Curr Top Med Chem       Date:  2020       Impact factor: 3.295

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.